Infrequent mutations of the TP53 gene and no amplification of the MDM2 gene in hepatoblastomas

被引:0
|
作者
Ohnishi, H
Kawamura, M
Hanada, R
Kaneko, Y
Tsunoda, Y
Hongo, T
Bessho, F
Yokomori, K
Hayashi, Y
机构
[1] UNIV TOKYO, FAC MED, DEPT PEDIAT, BUNKYO KU, TOKYO 113, JAPAN
[2] UNIV TOKYO, DEPT PEDIAT SURG, TOKYO, JAPAN
[3] SAITAMA CHILDRENS MED CTR, DEPT HEMATOL & ONCOL, IWATSUKI, SAITAMA, JAPAN
[4] SAITAMA CANC CTR HOSP, DEPT LAB MED, INA, SAITAMA, JAPAN
[5] SHOWA UNIV, SCH MED, DEPT SURG, TOKYO 142, JAPAN
[6] HAMAMATSU UNIV SCH MED, DEPT PEDIAT, SHIZUOKA, JAPAN
来源
GENES CHROMOSOMES & CANCER | 1996年 / 15卷 / 03期
关键词
D O I
10.1002/(SICI)1098-2264(199603)15:3<187::AID-GCC8>3.0.CO;2-Z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have investigated the mutation of the TP53 gene in hepatoblastomas (HBLs) by using polymerase chain reaction-single strand conformation polymorphism and direct sequencing in 38 HBL tumor samples and in two HBL cell lines. We detected the TP53 gene mutation in an anaplastic hepatoblastoma cell line, but no aberration of the TP53 gene (exons 5-9) was found in tumor samples and in the other HBL cell line. The mutation of the cell line was a missense mutation from GAC (asparagine) to CAC (histidine) at codon 281, which was different from the G-to-T transversion of codon 249 that is frequently found in adult hepatocellular carcinomas (HCCs). In addition, we performed Southern blot analysis of the MDM2 gene, but we did not find MDM2 gene amplification in 19 cases tested. Our results suggest that, in contrast to the findings in HCCs in adults, TP53 gene aberrations are not involved in the development or progression of HBLs in children. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:187 / 190
页数:4
相关论文
共 50 条
  • [1] TP53 mutations and MDM2 gene amplification in squamous-cell carcinomas of the esophagus in South Thailand
    Tanière, P
    Martel-Planche, G
    Puttawibul, P
    Casson, A
    Montesano, R
    Chanvitan, A
    Hainaut, P
    INTERNATIONAL JOURNAL OF CANCER, 2000, 88 (02) : 223 - 227
  • [2] MDM2 GENE AMPLIFICATION AND TRANSCRIPT LEVELS IN HUMAN SARCOMAS - RELATIONSHIP TO TP53 GENE STATUS
    FLORENES, VA
    MAELANDSMO, GM
    FORUS, A
    ANDREASSEN, A
    MYKLEBOST, O
    FODSTAD, O
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (17) : 1297 - 1302
  • [3] TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas
    Della Torre, G
    Pasquini, G
    Pilotti, S
    Alasio, L
    Civelli, E
    Cozzi, G
    Milella, M
    Salvetti, M
    Pierotti, MA
    Severini, A
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2000, 9 (01) : 41 - 46
  • [4] Gene abnormalities in multiple myeloma;: the relevance of TP53, MDM2, and CDKN2A
    Elnenaei, MO
    Gruszka-Westwood, AM
    A'Hern, R
    Matutes, E
    Sirohi, B
    Powles, R
    Catovsky, D
    HAEMATOLOGICA, 2003, 88 (05) : 529 - 537
  • [5] Common Polymorphisms in the MDM2 and TP53 Genes and the Relationship between TP53 Mutations and Patient Outcomes in Glioblastomas
    Zawlik, Izabela
    Kita, Daisuke
    Vaccarella, Salvatore
    Mittelbronn, Michel
    Franceschi, Silvia
    Ohgaki, Hiroko
    BRAIN PATHOLOGY, 2009, 19 (02) : 188 - 194
  • [6] TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients
    Di Vuolo, Valeria
    Buonaguro, Luigi
    Izzo, Francesco
    Losito, Simona
    Botti, Gerardo
    Buonaguro, Franco M.
    Tornesello, Maria Lina
    INFECTIOUS AGENTS AND CANCER, 2011, 6
  • [7] Germline mutations in the TP53 gene
    Eeles, RA
    CANCER SURVEYS, 1995, 25 : 101 - 124
  • [8] Chronic lymphocytic leukemia with MDM2 amplification as an alternative pathway to TP53 dysfunction
    Hunter, Sally
    Ryland, Georgina
    Pang, Jia-Min
    Ninkovic, Slavisa
    Dun, Karen
    Seymour, John F.
    Blombery, Piers
    LEUKEMIA & LYMPHOMA, 2024, 65 (14) : 2215 - 2218
  • [9] Common polymorphisms in TP53 and MDM2 and the relationship to TP53 mutations and clinical outcomes in women with ovarian and peritoneal carcinomas
    Galic, Vijaya
    Willner, Julia
    Wollan, Melissa
    Garg, Ruchi
    Garcia, Rochelle
    Goff, Barbara A.
    Gray, Heidi J.
    Swisher, Elizabeth M.
    GENES CHROMOSOMES & CANCER, 2007, 46 (03): : 239 - 247
  • [10] Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
    Fang, Shenying
    Krahe, Ralf
    Lozano, Guillermina
    Han, Younghun
    Chen, Wei
    Post, Sean M.
    Zhang, Baili
    Wilson, Charmaine D.
    Bachinski, Linda L.
    Strong, Louise C.
    Amos, Christopher I.
    PLOS ONE, 2010, 5 (05):